Development of a Chimeric Anti-CD40 Monoclonal Antibody That Synergizes with LEA29Y to Prolong Islet Allograft Survival-Reference-Cited by-同舟云学术

Development of a Chimeric Anti-CD40 Monoclonal Antibody That Synergizes with LEA29Y to Prolong Islet Allograft Survival

Published:2004-12-20 Issue:1 Volume:174 Page:542-550
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Adams Andrew B.,Shirasugi Nozomu,Jones Thomas R.,Durham Megan M.,Strobert Elizabeth A.,Cowan Shannon,Rees Phyllis,Hendrix Rose,Price Karen,Kenyon Norma S.,Hagerty David,Townsend Robert,Hollenbaugh Dianne,Pearson Thomas C.,Larsen Christian P.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference36 articles.

1. Immunotherapy as a means to induce transplantation tolerance

2. The Role of T-Cell Costimulatory Activation Pathways in Transplant Rejection

3. Complexities of CD28/B7: CTLA-4 Costimulatory Pathways in Autoimmunity and Transplantation

4. THE CD154-CD40 COSTIMULATORY PATHWAY IN TRANSPLANTATION

5. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

Cited by 176 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential induction of donor-reactive Foxp3+ regulatory T cell via blockade of CD154 vs CD40;American Journal of Transplantation;2024-08

2. CD40-CD40L Blockade: Update on Novel Investigational Therapeutics for Transplantation;Transplantation;2022-12-23

3. FcγRs and Their Relevance for the Activity of Anti-CD40 Antibodies;International Journal of Molecular Sciences;2022-10-25

4. Targeting inflammation and immune activation to improve CTLA4-Ig-based modulation of transplant rejection;Frontiers in Immunology;2022-09-02

5. An optimally designed anti-human CD40 antibody with potent B cell suppression for the treatment of autoimmune diseases;International Journal of Pharmaceutics;2021-11